Tema ETFs’s Terns Pharmaceuticals TERN Stock Holding History

Tema ETFs’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,244	Closed	-$414K	–	587
2025 Q4	$414K	Buy	+10,244	New	+$237K	0.03%	395
2025 Q1	–	Sell	-79,696	Closed	-$442K	–	169
2024 Q4	$442K	Buy	+79,696	New	+$540K	0.18%	104

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Tema ETFs's TERN Position: Q1 2026 in Review

Tema ETFs sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 10,244 shares — an estimated $414K sold.

Tema ETFs first reported a position in TERN in Q4 2024 and held it in 2 quarters. The position peaked at $442K in Q4 2024. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Tema ETFs reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Tema ETFs sold 10,244 Terns Pharmaceuticals shares in Q1 2026, an estimated $414K.
Tema ETFs first reported a position in Terns Pharmaceuticals in Q4 2024 and held it in 2 quarters.
Tema ETFs's Terns Pharmaceuticals position peaked at $442K in Q4 2024.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Tema ETFs's 13F filing for Q1 2026, filed 15 Apr 2026.